chrX-111757653-A-G
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001099922.3(ALG13):āc.3039A>Gā(p.Val1013Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000635 in 1,207,045 control chromosomes in the GnomAD database, including 5 homozygotes. There are 208 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001099922.3 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG13 | NM_001099922.3 | c.3039A>G | p.Val1013Val | synonymous_variant | 26/27 | ENST00000394780.8 | NP_001093392.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG13 | ENST00000394780.8 | c.3039A>G | p.Val1013Val | synonymous_variant | 26/27 | 2 | NM_001099922.3 | ENSP00000378260.3 |
Frequencies
GnomAD3 genomes AF: 0.00362 AC: 401AN: 110888Hom.: 3 Cov.: 22 AF XY: 0.00332 AC XY: 110AN XY: 33112
GnomAD3 exomes AF: 0.000953 AC: 169AN: 177262Hom.: 1 AF XY: 0.000598 AC XY: 39AN XY: 65254
GnomAD4 exome AF: 0.000325 AC: 356AN: 1096107Hom.: 2 Cov.: 30 AF XY: 0.000252 AC XY: 91AN XY: 361697
GnomAD4 genome AF: 0.00370 AC: 410AN: 110938Hom.: 3 Cov.: 22 AF XY: 0.00353 AC XY: 117AN XY: 33172
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 36 Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 30, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 30, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 28, 2017 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 21, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
ALG13-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 02, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at